|
Eichen Levinson Crutchlow, LLP is part of the legal team that has recently filed a nationwide consumer fraud class action against Schering-Plough, in connection with its illegal marketing of Temodar, Intron-A, PEG-Intron, the Intron Franchise, and Rebetol.
The lawsuit alleges that Schering engaged in a campaign of illegally marketing the drugs for uses that were not approved by the US Food & Drug Administration. As part of that illegal marketing campaign, the lawsuit alleges that Schering coordinated a campaign of bribery and kickbacks to doctors in order to induce them into prescribing those particular drugs even when not warranted, or at higher doses than necessary, or for longer periods than necessary.
If you are either a consumer who was prescribed or a health plan that has paid for the prescribing of any of the following Schering-Plough drugs, we would like to hear from you:
- Temodar
- Intron-A
- PEG-Intron
- Intron Franchise
- Rebetol
We would also like to hear from you are a consumer who was prescribed or
a health plan that has paid for prescribing:
|
